GG
GordonMD Global Investments LP disclosed a 16.4% stake in PYXS
GordonMD Global Investments LP reported owning 16.4% of Pyxis Oncology, Inc. (PYXS) (20,441,948 shares) in a Schedule 13G filed Oct 9, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.